|Articles|September 1, 2012

Pharmaceutical Technology Europe

  • Pharmaceutical Technology Europe-09-01-2012
  • Volume 24
  • Issue 9

Pharmaceutical Technology Europe, September 2012 Issue (PDF)

Click the title above to open the Pharmaceutical Technology Europe September 2012 issue in an interactive PDF format.

Articles in this issue

about 14 years ago

The Macro View

about 14 years ago

Strategies for High Containment

about 14 years ago

Tackling Tablet Sticking

about 14 years ago

News

Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.